SLC6A3 and Parkinson disease: Confirming these preliminary observations, ANCOVA analyses (adjusted for age and APOE genotype) indicated that the DAT SBr in these regions were significantly different across the three groups (p < 0.001), with subjects with Parkinson’s disease demonstrating highly reduced DAT SBr in the regions (see Supplementary Table S1).